ERC-SG-LS7
ERC-SG-LS7
Programme: H2020
106 projects · €153,161,413 total EU contribution (project-level) · 97 participating organizations · 17 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€153,161,413
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (14)
- Germany (13)
- Netherlands (11)
- Spain (10)
- Italy (9)
- IL (6)
- CH (5)
- DK (5)
- France (5)
- BE (4)
- SE (4)
- EL (3)
- FI (3)
- EE (1)
- HU (1)
- IE (1)
- PT (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5 projects · UK
- UNIVERSITY COLLEGE LONDON4 projects · —
- AU3 projects · DK
- EPFL3 projects · CH
- FONDAZIONE TELETHON ETS3 projects · IT
- HELSINGIN YLIOPISTO3 projects · FI
- INSERM3 projects · FR
- BGU2 projects · IL
- CEA2 projects · FR
- ETH Zürich2 projects · CH
- HMGU2 projects · DE
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2 projects · UK
Projects
Page 9 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Rapid Adaptive Nonlinear Gradient Encoding for Magnetic Resonance Imaging RANGEMRI · 282345 | FP7 | €1,497,672 | €1,497,672 | Details |
Full biomechanical characterization of the coronary atherosclerotic plaque: biomechanics meets imaging BIOCCORA · 310457 | FP7 | €1,877,000 | €1,877,000 | Details |
Transporter pharmacogenomics – the contribution of transporters to variability in drug response TRANSPORTERPGX · 282106 | FP7 | €1,882,212 | €1,882,212 | Details |
Unravelling environmental exposures in the core axis of ageing ENVIRONAGE · 310898 | FP7 | €1,473,910 | €1,473,910 | Details |
Manipulation of senescence pathways for cancer therapy: from experimental models to clinic PICS THERAPY · 261342 | FP7 | €1,500,000 | €1,500,000 | Details |
Multimodal tools for Molecular Imaging, Diagnostics and Therapeutics MUMID · 260604 | FP7 | €1,498,800 | €1,498,800 | Details |
Easy and rapid generation of light-emitting somatic-transgenic mice to monitor specific disease states and to screen effective drugs SOMABIO · 260862 | FP7 | €1,471,272 | €1,471,272 | Details |
Nature-inspired theranostic nanodevices for tumor imaging, early diagnosis and targeted drug-release NATURE NANODEVICES · 336493 | FP7 | €1,458,600 | €1,458,600 | Details |
Alcohol Consumption across the Life-course: Determinants and Consequences ALCOHOLLIFECOURSE · 309337 | FP7 | €1,032,815 | €1,032,815 | Details |
Developing Multispecific Biological Agents that Target Tumor Neovasculature for Cancer Imaging and Therapy BISPROT · 336041 | FP7 | €1,625,000 | €1,625,000 | Details |